SIC: 2834 - PHARMACEUTICAL PREPARATIONS
State location: MA | State of Inc.: DE | Fiscal Year End: 1231
(CF Office: 03 Life Sciences)
Get insider transactions for this issuer.
File Number: 005-92302
Filings | Format | Description | Filing Date | File/Film Number |
---|---|---|---|---|
SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-24-023911 (34 Act) Size: 136 KB |
2024-02-14 | 005-92302 24639908 |
SC 13D/A | Documents | [Amend] General Statement of Acquisition of Beneficial Ownership Acc-no: 0001104659-23-104277 (34 Act) Size: 58 KB |
2023-09-27 | 005-92302 231284790 |
SC 14D9/A | Documents | [Amend] Solicitation, recommendation statements Acc-no: 0001193125-23-240970 (34 Act) Size: 19 KB |
2023-09-25 | 005-92302 231273210 |
SC TO-T/A | Documents | [Amend] Tender offer statement by Third Party Acc-no: 0001104659-23-103362 (34 Act) Size: 101 KB |
2023-09-25 | 005-92302 231273196 |
SC TO-T/A | Documents | [Amend] Tender offer statement by Third Party Acc-no: 0001104659-23-100041 (34 Act) Size: 77 KB |
2023-09-12 | 005-92302 231250585 |
SC 14D9/A | Documents | [Amend] Solicitation, recommendation statements Acc-no: 0001193125-23-233464 (34 Act) Size: 200 KB |
2023-09-12 | 005-92302 231250227 |
SC 14D9/A | Documents | [Amend] Solicitation, recommendation statements Acc-no: 0001193125-23-231574 (34 Act) Size: 19 KB |
2023-09-08 | 005-92302 231245605 |
SC TO-T/A | Documents | [Amend] Tender offer statement by Third Party Acc-no: 0001104659-23-099290 (34 Act) Size: 68 KB |
2023-09-08 | 005-92302 231245331 |
SC 14D9 | Documents | Solicitation, recommendation statements Acc-no: 0001193125-23-220927 (34 Act) Size: 544 KB |
2023-08-25 | 005-92302 231204109 |
SC TO-T | Documents | Tender offer statement by Third Party Acc-no: 0001104659-23-095116 (34 Act) Size: 12 MB |
2023-08-25 | 005-92302 231203803 |
SC 13D | Documents | General Statement of Acquisition of Beneficial Ownership Acc-no: 0001104659-23-093555 (34 Act) Size: 314 KB |
2023-08-18 | 005-92302 231186702 |
SC14D9C | Documents | Written communication relating to third party tender offer Acc-no: 0001193125-23-207468 (34 Act) Size: 372 KB |
2023-08-09 | 005-92302 231156025 |
SC TO-C | Documents | Written communication relating to an issuer or third party Acc-no: 0001104659-23-089313 (34 Act) Size: 257 KB |
2023-08-09 | 005-92302 231155354 |
SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-23-020734 (34 Act) Size: 137 KB |
2023-02-14 | 005-92302 23622640 |
SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001306550-23-006964 (34 Act) Size: 13 KB |
2023-02-03 | 005-92302 23584591 |
SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001193125-22-042110 (34 Act) Size: 138 KB |
2022-02-14 | 005-92302 22634312 |
SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001193125-22-040723 (34 Act) Size: 259 KB |
2022-02-14 | 005-92302 22628116 |
SC 13G/A | Documents | [Amend] Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-22-021112 (34 Act) Size: 139 KB |
2022-02-14 | 005-92302 22624600 |
SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-22-020463 (34 Act) Size: 44 KB |
2022-02-11 | 005-92302 22620704 |
SC 13D | Documents | General Statement of Acquisition of Beneficial Ownership Acc-no: 0000947871-21-000278 (34 Act) Size: 145 KB |
2021-03-02 | 005-92302 21700180 |
SC 13G | Documents | Statement of Beneficial Ownership by Certain Investors Acc-no: 0001104659-21-029968 (34 Act) Size: 170 KB |
2021-03-01 | 005-92302 21697613 |